🇺🇸 FDA
Patent

US 7816532

Biphenyl compounds useful as muscarinic receptor antagonists

granted A61PA61P11/00A61P11/06

Quick answer

US patent 7816532 (Biphenyl compounds useful as muscarinic receptor antagonists) held by Theravance, Inc. expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P11/00, A61P11/06, A61P11/08, A61P43/00